UBS OCONNOR LLC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$654,416
-4.5%
59,764
+15.5%
0.02%
-27.3%
Q2 2023$685,355
-27.3%
51,764
-25.3%
0.02%
-24.1%
Q1 2023$943,173
-99.9%
69,300
+20.5%
0.03%
+38.1%
Q3 2022$1,095,000,000
+1.2%
57,500
+9.5%
0.02%
+31.2%
Q2 2022$1,082,000,00052,5000.02%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders